ArticleScientific reports2025
Silver nanoparticles coated with metabolites of Pseudomonas sp. N5.12 inhibit bacterial pathogens and fungal phytopathogens.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- New herbicide-degrading microorganisms for the biogenic synthesis of silver nanoparticles.Archives of microbiology · 2026Article
- Antibacterial and antivirulence activity of biosynthesized silver nanoparticles by Pseudomonas lurida against several plant pathogenic bacteria.Scientific reports · 2026Article
- Inhibitory activity of silver nanoparticles on Staphylococcus aureus growth and α-hemolysin gene expression.Molecular biology reports · 2026Article
- Postharvest delivery of Bacillus G36 metabolites formulated in AgNP modifies Salvia rosmarinus Spenn. bioactive profiles.Scientific reports · 2026Article
- Influence of Silver Nanoparticles (AgNPs) on Vegetative Growth and Concentrations of Nutrients and Phytohormones in Tomato.Plants (Basel, Switzerland) · 2026Article
- Integrated genome mining and phytohormone profiling of six plant growth-promoting elite bacterial strains.Archives of microbiology · 2026Article
- Endophyte-mediated biosynthesis of biogenic nanoparticles: mechanisms and biomedical applications.Archives of microbiology · 2026Review
- The Antimicrobial and Cytotoxic Activity of Green-Synthesized Silver Nanoparticle Extract of Marine Bacteria and Their 16S rRNA Identification and Characterization.Bioinorganic chemistry and applications · 2026Article
- Microfluidic Platform for Predicting Nanoparticle Dynamics in Cancer Therapeutics.Journal of fluorescence · 2025Article
- Microbial-Based Green Synthesis of Silver Nanoparticles: A Comparative Review of Bacteria- and Fungi-Mediated Approaches.International journal of molecular sciences · 2025Review
- Enhanced Anti-Inflammatory Effects of Rosemary (Antioxidants (Basel, Switzerland) · 2025Article
- Article
- AgNPs biosynthesized fromFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The synthesis of nanomaterials from PGPB is an exciting approach and it's often used in agriculture as nano-fertilizers and nano-pesticides. The present study reports a new approach to biosynthesis of silver nanoparticles (AgNP), using bacterial metabolites as agents to reduce Ag
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.